|Videos|December 19, 2019
Navigating the Complex Treatment Landscape of Multiple Myeloma in Transplant Eligible Patients
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Phase 2 Study Shows Feasibility of Axi-Cel Delivery in Outpatient Setting
September 13th 2025
- Refined iRR6 Model Improves Risk Stratification in Intermediate-1 Myelofibrosis
September 12th 2025
- COVID-19 Risk Remains High for Patients With Hematologic Malignancies
September 10th 2025
- Navigating Cilta-Cel Sequencing in Multiple Myeloma: Surbhi Sidana, MD, MBBS
September 10th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5